Berberine Ameliorates Diabetic Cardiomyopathy in Mice by Decreasing Cardiomyocyte Apoptosis and Oxidative Stress
Background: Diabetic cardiomyopathy is a multifaceted complication of diabetes that lacks effective treatments. Berberine (BBR), a bioactive compound from Rhizoma coptidis , has potential therapeutic implications, but its precise role in diabetic cardiomyopathy remains to be defined. Methods: In...
Main Authors: | Xiaoqiang Sun, Zhuqing Li, Li Wang, Yanxin Wang, Chengzhi Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2023-10-01
|
Series: | Cardiovascular Innovations and Applications |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0064 |
Similar Items
-
Mogroside IIe Ameliorates Cardiomyopathy by Suppressing Cardiomyocyte Apoptosis in a Type 2 Diabetic Model
by: Xin Cai, et al.
Published: (2021-05-01) -
GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress
by: Yue Wang, et al.
Published: (2018-07-01) -
Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice
by: Fei Xue, et al.
Published: (2022-08-01) -
Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy
by: Manli Yu, et al.
Published: (2022-10-01) -
Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression.
by: Xiuxiu Lv, et al.
Published: (2012-01-01)